BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14515294)

  • 1. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.
    Sugiyama M; Izumisato Y; Abe N; Masaki T; Mori T; Atomi Y
    Br J Surg; 2003 Oct; 90(10):1244-9. PubMed ID: 14515294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
    Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
    J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of intraductal papillary-mucinous tumor (IPMT) of the pancreas: operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT.
    Seki M; Yanagisawa A; Ohta H; Ninomiya Y; Sakamoto Y; Yamamoto J; Yamaguchi T; Ninomiya E; Takano K; Aruga A; Yamada K; Sasaki K; Kato Y
    J Hepatobiliary Pancreat Surg; 2003; 10(2):147-55. PubMed ID: 14505148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of malignancy in intraductal papillary mucinous neoplasms of the pancreas, especially in relation to dysplastic epithelial changes.
    Mizumoto M; Honjo G; Kobashi Y; Nishimura S; Nakamura Y; Yoshimura T; Awane M; Kato Y; Furuyama H; Asao Y; Maeda H; Takakuwa H; Matsusue S
    Hepatogastroenterology; 2008; 55(82-83):704-7. PubMed ID: 18613438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
    Passot G; Lebeau R; Hervieu V; Ponchon T; Pilleul F; Adham M
    Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
    Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.